Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Journal of Pharmacy Practice|January 17, 2022
Key Points for Pharmacists From the ACC Expert Consensus Decision Pathway for Patients Hospitalized With Heart FailureKatie B Tellor, Anastasia L ArmbrusterThe Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|August 19, 2024
Evaluation of Apixaban Use in Patients With Advanced Kidney DiseaseConner McClain, Amanda R Buckallew, Anastasia L ArmbrusterThe Annals of Pharmacotherapy|April 10, 2015
Edoxaban, a Novel Oral Factor Xa InhibitorChelsea Minor, Katie B Tellor, Anastasia L ArmbrusterAmerican Journal of Pharmaceutical Education|April 2, 2022
A Call to Action for a Programmatic Approach to Addressing Health Disparities and Cultural Competency in Pharmacy EducationAnastasia L Armbruster, Brianna N Henson, Naser Z AlsharifThe Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Extended-Duration Venous Thromboembolism Prophylaxis in Hospitalized Acutely Ill Medical Patients: A Review of the EvidenceKatie B Tellor, Anastasia L Armbruster, James M HollandsTherapeutics and Clinical Risk Management|May 25, 2016
Comparative risk impact of edoxaban in the management of stroke and venous thromboembolismKatie B Tellor, Joseph S Van Tuyl, Anastasia L ArmbrusterThe Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Evaluation of Apixaban for the Treatment of Nonvalvular Atrial Fibrillation With Regard to Dosing and Safety in a Community HospitalKatie B Tellor, Michelle Wang, Melissa S Green, et al.Journal of Community Hospital Internal Medicine Perspectives|March 5, 2020
Evaluating the safety and tolerability of inpatient sacubitril/valsartan initiation in a community hospitalKatie L Peppin, Katie B Tellor, Anastasia L Armbruster, et al.Therapeutic Advances in Cardiovascular Disease|July 8, 2020
Flecainide is well-tolerated and effective in patient with atrial fibrillation at 12 months: a retrospective studyMikayla Muzzey, Katie B Tellor, Karthik Ramaswamy, et al.Pharmacotherapy|January 31, 2022
The role of inflammation in the pathogenesis and treatment of arrhythmiasAnastasia L Armbruster, Kristen Bova Campbell, Milan G Kahanda, et al.Pageof 3